nature.com
about npg
news@nature.com
naturejobs
natureevents
help
site index
my account
Submit Manuscript
subscribe
register
SEARCH
Sunday 23 November 2008
Home
News
Research highlights
Research & reviews
Naturejobs drug discovery
Market analysis
About this site
Resources
Horizon
Nature Reviews Drug Discovery
Nature
Nature Biotechnology
Nature Chemical Biology
Nature Medicine
Nature Structural & Molecular Biology
Nature Methods
British Journal of Pharmacology
The Pharmacogenomics Journal
Bioentrepreneur
Neuropsycho-
pharmacology
Molecular Psychiatry
Signaling Gateway
Pathway Interaction Database
Functional Glycomics Gateway
Neuroscience Gateway
Clinical Pharmacology & Therapeutics
Nature Reports Stem Cells
Nature Reports Avian Flu
Research & reviews
This month's research & review articles
Novel therapeutic strategies for multiple sclerosis – a multifaceted adversary
Understanding of the immunopathogenesis of multiple sclerosis has opened up exciting avenues and novel potential targets to affect the natural course of the disease.
31 October 2008
New regulators of NF-κB in inflammation
Approaches to target NF-κB in inflammatory disease must consider the varied contributions of the NF-[kappa]B transcription-factor family in various signalling pathways.
31 October 2008
Network pharmacology: the next paradigm in drug discovery
Network pharmacology: the next paradigm in drug discovery
31 October 2008
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2
Valproic acid, a histone deacetylase inhibitor, enables reprogramming of primary human fibroblasts with only two factors, Oct4 and Sox2, without the need for the oncogenes c-Myc or Klf4.
31 October 2008
Home
|
News
|
Research highlights
|
Research & reviews
|
Naturejobs drug discovery
Market analysis
|
About this site
© 2008 Nature Publishing Group
Privacy Policy